We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 41.61%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+41.61%
3 Year Est. Return
+119.85%
5 Year Est. Return
+166.26%
10 Year Est. Return
+656.19%
AUM
$1.81B
AUM Growth
+$26M
Cap. Flow
-$52.9M
Cap. Flow %
-2.92%
Top 10 Hldgs %
20.25%
Holding
148
New
7
Increased
37
Reduced
57
Closed
24

Sector Composition

Rank Sector Weight
1 Industrials 19.41%
2 Technology 18.78%
3 Consumer Staples 17.03%
4 Consumer Discretionary 8.71%
5 Healthcare 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
76
Emerson Electric
EMR
$83.3B
$3.14M 0.17%
57,792
-7,000
-11% -$338K
EFX icon
77
Equifax
EFX
$20.7B
$3.12M 0.17%
27,291
-475
-2% -$50K
IFF icon
78
International Flavors & Fragrances
IFF
$20.3B
$2.46M 0.14%
21,670
-212,541
-91% -$23.8M
PFE icon
79
Pfizer
PFE
$142B
$2.17M 0.12%
77,058
-8,432
-10% -$241K
KHC icon
80
Kraft Heinz
KHC
$31.3B
$2.01M 0.11%
25,538
-1,596
-6% -$119K
WY icon
81
Weyerhaeuser
WY
$16.9B
$2M 0.11%
64,627
+56,127
+660% +$1.5M
WELL icon
82
Welltower
WELL
$170B
$1.46M 0.08%
21,075
+300
+1% +$19.3K
DUK icon
83
Duke Energy
DUK
$98.4B
$1.39M 0.08%
17,248
-9,249
-35% -$700K
ABB
84
DELISTED
ABB Ltd
ABB
$1.2M 0.07%
61,680
-64,275
-51% -$1.14M
UN
85
DELISTED
Unilever NV New York Registry Shares
UN
$1.18M 0.07%
26,500
BNS icon
86
Scotiabank
BNS
$107B
$1.15M 0.06%
24,017
PH icon
87
Parker-Hannifin
PH
$121B
$1.13M 0.06%
10,175
-1,087
-10% -$109K
BMY icon
88
Bristol-Myers Squibb
BMY
$132B
$1.11M 0.06%
17,455
-1,500
-8% -$94.6K
BRK.B icon
89
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.11M 0.06%
7,850
NEE icon
90
NextEra Energy
NEE
$183B
$1M 0.06%
33,980
-10,800
-24% -$303K
CP icon
91
Canadian Pacific Kansas City
CP
$78.3B
$993K 0.05%
37,425
-3,500
-9% -$85.3K
DNB
92
DELISTED
Dun & Bradstreet
DNB
$906K 0.05%
8,785
-980
-10% -$95.2K
FLR icon
93
Fluor
FLR
$6.99B
$875K 0.05%
16,295
TFC icon
94
Truist Financial
TFC
$63.5B
$875K 0.05%
26,300
-8,392
-24% -$279K
GILD icon
95
Gilead Sciences
GILD
$163B
$868K 0.05%
9,451
-16,515
-64% -$1.49M
RY icon
96
Royal Bank of Canada
RY
$292B
$836K 0.05%
14,527
RTX icon
97
RTX Corp
RTX
$289B
$816K 0.05%
12,950
INGR icon
98
Ingredion
INGR
$6.33B
$795K 0.04%
7,445
CAT icon
99
Caterpillar
CAT
$373B
$786K 0.04%
10,265
-6,000
-37% -$402K
CVS icon
100
CVS Health
CVS
$134B
$707K 0.04%
6,820
+625
+10% +$60.8K

Similar funds

Bowen Hanes & Co's Q1 2016 Portfolio in Review

As of Q1 2016, Bowen Hanes & Co held 148 positions worth $1.81B, up 1.5% from $1.79B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Bowen Hanes & Co's Q1 2016 filing shows 7 new, 37 increased, 57 reduced and 24 closed positions. Its largest new stake was Henry Schein: 320,752 shares worth $21.7M. The largest sale was Textron, an estimated $25.4M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Staples.

  • Bowen Hanes & Co's largest Q1 2016 buy was Henry Schein: 320,752 shares worth $21.7M.
  • Bowen Hanes & Co added most to VCA Inc. in Q1 2016, an estimated $15.8M increase.
  • Bowen Hanes & Co's biggest Q1 2016 reduction was International Flavors & Fragrances, cutting an estimated $23.8M.
  • Bowen Hanes & Co fully exited Textron in Q1 2016, selling an estimated $25.4M.
  • Bowen Hanes & Co's ten largest holdings make up 20% of its $1.81B portfolio in Q1 2016.
  • Bowen Hanes & Co opened 7 new positions and closed 24 in Q1 2016.
  • Bowen Hanes & Co's portfolio value rose 1.5% quarter-over-quarter to $1.81B.

Based on Bowen Hanes & Co's 13F filing for Q1 2016, filed 16 May 2016.